Cited by 62Antifungal resistance and susceptibilityFungal and yeast genetics researchFungal Infections and Studies

Fob1 and Fob2 proteins are virulence determinants of Rhizopus oryzae via facilitating iron uptake from Ferrioxamine

Open access
Liu, Mingfu, Lin, Lin, Gebremariam, Teclegiorgis, Luo, Guanpingsheng, Skory, Christopher D., French, Samuel W., Chou, Tsui-Fen, Edwards, John E. +1 more·2015·PLOS Pathogens

Abstract

Dialysis patients with chronic renal failure receiving deferoxamine for treating iron overload are uniquely predisposed for mucormycosis, which is most often caused by Rhizopus oryzae. Although the deferoxamine siderophore is not secreted by Mucorales, previous studies established that Rhizopus species utilize iron from ferrioxamine (iron-rich form of deferoxamine). Here we determined that the CBS domain proteins of Fob1 and Fob2 act as receptors on the cell surface of R. oryzae during iron uptake from ferrioxamine. Fob1 and Fob2 cell surface expression was induced in the presence of ferrioxamine and bound radiolabeled ferrioxamine. A R. oryzae strain with targeted reduced Fob1/Fob2 expression was impaired for iron uptake, germinating, and growing on medium with ferrioxamine as the sole source of iron. This strain also exhibited reduced virulence in a deferoxamine-treated, but not the diabetic ketoacidotic (DKA), mouse model of mucormycosis. The mechanism by which R. oryzae obtains iron from ferrioxamine involves the reductase/permease uptake system since the growth on ferrioxamine supplemented medium is associated with elevated reductase activity and the use of the ferrous chelator bathophenanthroline disulfonate abrogates iron uptake and growth on medium supplemented with ferrioxamine as a sole source of iron. Finally, R. oryzae mutants with reduced copies of the high affinity iron permease (FTR1) or with decreased FTR1 expression had an impaired iron uptake from ferrioxamine in vitro and reduced virulence in the deferoxamine-treated mouse model of mucormycosis. These two receptors appear to be conserved in Mucorales, and can be the subject of future novel therapy to maintain the use of deferoxamine for treating iron-overload.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1004842

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • DFO can be used as an iron source because iron-laden DFO is ingested by Rhizopus oryzae through siderophore receptors Fob1 and Fob2.

    “Although DFX is a semisynthetic compound, another iron chelator, DFO, can be used as an iron source as iron-laden DFO is ingested by Rhizopus oryzae through siderophore receptors Fob1 and Fob2 (Liu et al., 2015).”

    From Iron in infection and immunity (2020) · cites this paper as Liu et al., 2015

    The Discussion identifies iron-laden DFO (ferrioxamine) as an iron source for R. oryzae and Fob1/Fob2 as its cell-surface receptors. But its proposed primary mechanism is uptake of iron after ferrioxamine binds those receptors, not ingestion of the iron-laden DFO complex; it describes transport of the whole complex only as a possible secondary pathway. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [23]Kwon-Chung KJ, Bennett JE (1992) Mucormycosis Medical Mycology. Philadelphia: Lea & Febiger pp. 524– 559.
  2. [49]de Locht M, Boelaert JR, Schneider YJ (1994) Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of Rhizopus microsporus. Biochem Pharmacol 47: 1843– 1850. 8204101

Cited by

Sorted by citations

Authors
Liu, M., Lin, L., Gebremariam, T., Luo, G., Skory, C. D., French, S. W., Chou, T.-F., Edwards, J. E., & Ibrahim, A. S.
Affiliations
  • University of California, Los Angeles (US)
  • United States Department of Agriculture (US)
Corresponding author
  • Liu, Mingfu
  • Lin, Lin
  • Gebremariam, Teclegiorgis
  • Luo, Guanpingsheng
  • Skory, Christopher D.
  • French, Samuel W.
  • Chou, Tsui-Fen
  • Edwards, John E.
  • Ibrahim, Ashraf S.
Venue
PLOS Pathogens
Published
2015-05-14
Volume
11
Issue
5
Pages
e1004842
ISSN
  • 1553-7366 (ISSN-L)
  • 1553-7374
OpenAlex
W1537624486
Cited by
62
References
71
Citations by year
2026: 2 · 2025: 4 · 2024: 4 · 2023: 6 · 2022: 8 · 2021: 11 · 2020: 8 · 2019: 5 · 2018: 8 · 2017: 6
FWCI
3.63
Type
journal article
Language
en
Open access
Locations
  • PLoS Pathogens (publishedVersion, public-domain)
  • Europe PMC (PubMed Central) (publishedVersion, public-domain)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • CaltechAUTHORS (California Institute of Technology) (submittedVersion, public-domain)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, public-domain)
  • Figshare (submittedVersion, cc-by)
Funders
National Institute of Allergy and Infectious Diseases (R01AI063503)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
Keywords
Rhizopus oryzae, Fob1, ferrioxamine, iron absorption, siderophore receptors, mucormycosis, deferoxamine, iron overload, reductase activity, fungal virulence, Mucorales
MeSH terms
Animals, Biological Transport, Deferoxamine, DNA-Binding Proteins, Ferric Compounds, Iron, Iron Chelating Agents, Membrane Glycoproteins, Mucormycosis, Rhizopus, Siderophores, Membrane Transport Proteins, Saccharomyces cerevisiae Proteins, Virulence Factors, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review